Which Weight Loss Injection Offers Better Value?
Wegovy V Saxenda Discount Codes: Maximise Your Savings
When comparing Wegovy v Saxenda costs, discount codes can significantly impact your treatment budget. EverydayMeds offers two exclusive codes: FIRST40 for new customers and DOSE25 for returning patients, both applied at checkout to reach our competitive pricing. Wegovy's 0.25mg starter dose costs £79.99 after the discount code, whilst the maintenance 2.4mg dose is £209.99. Our bundle options provide additional convenience, such as the Intro Duo (0.25mg & 0.5mg pens) for £169.99, covering your first two months.
The application process is straightforward: complete your 3-minute clinical assessment, add your chosen dose to basket, enter your discount code at checkout, and proceed to prescriber review. These codes are built into our pricing strategy to ensure both Wegovy and Saxenda remain accessible options. Your prescriber can help determine which treatment aligns with your clinical needs and budget considerations during the assessment process.
Wegovy V Saxenda Pricing Structures Compared
Understanding the cost differences between Wegovy v Saxenda requires examining their distinct dosing approaches. Wegovy follows a structured 16-week escalation: starting at £79.99 for 0.25mg, progressing through £94.99 (0.5mg) and £99.99 (1mg), reaching £139.99 for 1.7mg, before the maintenance 2.4mg dose at £209.99. Each pen provides four weeks of treatment with once-weekly injections. Saxenda operates differently with daily injections, requiring multiple pens per month at varying dose levels.
Bundle pricing offers convenience for committed patients, with our Progress Trio (0.5mg, 1mg & 1.7mg) available for £369.99, providing three months of step-up dosing. The Ultimate Stability Trio delivers three months of 2.4mg maintenance doses for £649.99. Both discount codes (FIRST40 and DOSE25) apply to individual pens and bundle purchases, making either Wegovy or Saxenda more budget-friendly through our GPhC-registered pharmacy (#9012878).
Wegovy V Saxenda Clinical Evidence Overview
The STEP trial programme demonstrated Wegovy's efficacy in clinical settings, with Wilding et al. (NEJM, 2021) reporting average weight loss of approximately 15% at 68 weeks when combined with lifestyle interventions. STEP 1 showed sustained results over 68 weeks, whilst STEP 5 confirmed maintenance of weight loss over 2 years. The recent SELECT cardiovascular outcomes trial indicated a 20% reduction in major cardiovascular events.
Saxenda's clinical profile comes from the SCALE trial programme, showing its own distinct efficacy patterns with daily liraglutide administration. When comparing Wegovy v Saxenda trial data, it's important to note these studies used different designs, populations, and endpoints, making direct comparisons challenging. Both treatments require prescription-only medicine status and clinical assessment before initiation.
How Wegovy V Saxenda Mechanisms Differ
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of natural incretin hormones in your digestive system. When injected once weekly, it may help reduce appetite by acting on brain centres that control hunger and satiety. The medication can promote feelings of fullness after smaller meals and may reduce food cravings throughout the week. Saxenda uses liraglutide, an earlier GLP-1 receptor agonist requiring daily injections, with a shorter duration of action. Both work by slowing gastric emptying and influencing appetite regulation, but their different dosing schedules mean varied daily hormone exposure patterns.
Wegovy V Saxenda Ordering Process Simplified
Accessing either Wegovy or Saxenda through EverydayMeds follows our streamlined three-step process designed for busy lives. Complete the 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Your responses undergo review by our qualified prescribers, typically within 3 working days (express 24-hour option available). Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics. Remember to apply discount code FIRST40 (new customers) or DOSE25 (returning patients) at checkout to access our competitive pricing structure.
Wegovy V Saxenda Storage and Practical Considerations
Storage requirements differ between these weight management injections, potentially influencing your choice. Wegovy pens require refrigeration at 2–8°C before first use but offer superior travel flexibility with 6 weeks room temperature storage below 30°C once removed from the fridge. Saxenda has more restrictive storage parameters with shorter room temperature tolerance. The FlexTouch pen design is identical for both medications, featuring pre-filled, single-use injection pens with built-in needles. Dose escalation is mandatory for Wegovy over 16 weeks to minimise gastrointestinal side effects, whilst Saxenda follows its own titration schedule. Both require injection technique training, provided through our comprehensive patient support materials.
Wegovy V Saxenda Discount Code Strategy for Long-term Treatment
Smart patients planning long-term weight management often ask about maximising savings when comparing Wegovy v Saxenda costs. Our discount codes work differently for each medication due to their distinct dosing patterns. FIRST40 and DOSE25 codes apply to every order, whether you're purchasing starter doses, maintenance supplies, or convenience bundles. Consider the total monthly cost: Wegovy requires one pen monthly at maintenance (£209.99 for 2.4mg), whilst Saxenda needs multiple pens due to daily dosing.
Bundle purchasing can simplify your ordering schedule whilst maintaining discount code benefits. The Intro Trio bundle provides your first three months of Wegovy escalation (0.25mg, 0.5mg, 1mg) for £299.99 with discount codes applied. This approach reduces ordering frequency and ensures consistent supply during the critical initial phase when side effect management and dose progression matter most for treatment success.
Wegovy V Saxenda: Making Your Final Decision
Your choice between Wegovy v Saxenda ultimately depends on clinical suitability, lifestyle preferences, and cost considerations. Wegovy's once-weekly dosing may suit busy schedules, whilst its newer formulation reflects recent advances in GLP-1 receptor agonist technology. Saxenda's daily dosing provides consistent hormone exposure but requires more frequent injections. Both medications are available through EverydayMeds with identical clinical assessment standards, prescriber oversight, and customer support. Our qualified prescribers can help determine which option aligns with your medical history, weight management goals, and practical preferences. Take advantage of our discount codes to start your weight management journey: FIRST40 for new customers or DOSE25 for returning patients, applied at checkout on our secure ordering platform.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
